ParDrugs PAR full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• IntraDay predictions, targets, What to do PAR
• Forcast & Targets PAR
• PAR Experts view
• Tomorrow's Movement PAR
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• PAR History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of ParDrugs

Tomorrow's movement Prediction of Par Drugs PAR appears to be in downtrend.

And this trend seems to be continuing further.

Price is below an important level of 91.31 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Par Drugs PAR made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Munafa value: 25 as on Thu 04 December 2025

This Munafa value indicates that the stock is moving downwards and might continue to move down.

SMA20 is at 93 and price is deviating by 4 points

Upper Bollinger band is at 100 and lower is at 86, while middle bands are at 90 and 97

Price is rising

Price is below 20day SMA

Price is in lower range of bands

Price action analysis of ParDrugs (PAR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for ParDrugs stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for ParDrugs in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

ParDrugs Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for ParDrugs in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of ParDrugs is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 89.36 and ParDrugs PAR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the ParDrugs PAR stock. Volume based technical analysis of ParDrugs PAR stock is negative.

ParDrugs Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Par Drugs PAR

DMA (daily moving average) of Par Drugs PAR

DMA period	DMA value
5 day DMA	88.73
12 day DMA	90.26
20 day DMA	92.67
35 day DMA	115.35
50 day DMA	143.27
100 day DMA	203.45
150 day DMA	215.7
200 day DMA	220.88

EMA (exponential moving average) of Par Drugs PAR

EMA period	EMA current	EMA prev	EMA prev2
5 day EMA	88.53	88.87	90.16
12 day EMA	91.31	91.94	92.97
20 day EMA	98.51	99.63	101.03
35 day EMA	121.06	123.01	125.17
50 day EMA	144.66	146.98	149.46

SMA (simple moving average) of Par Drugs PAR

SMA period	SMA current	SMA prev	SMA prev2
5 day SMA	88.73	89.09	89.95
12 day SMA	90.26	90.78	91.43
20 day SMA	92.67	93.24	93.88
35 day SMA	115.35	118.61	122.26
50 day SMA	143.27	145.97	148.74
100 day SMA	203.45	204.89	206.35
150 day SMA	215.7	216.71	217.75
200 day SMA	220.88	221.7	222.55

Fundamentals, profit and EPS of Par Drugs PAR

EPS is 11.51 and PE is: 7.63

Last quarter profit: (June 2025 quarter) 3.33 crores (31.62%)

Debt: 0.00 in crores

Market capitalization: 118.63

EPS is 10.86 and PE is: 8.09

Last quarter profit: (March 2025 quarter) 1.65 crores (-55.65%)

Debt: 0.00 in crores

Market capitalization: 124.33

Videos related to: ParDrugs PAR full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI